Education
About Us
Working with TipRanks
Follow Us
Performant Healthcare (PHLT)
NASDAQ:PHLT
Earnings Data
Report Date
May 13, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.02Last Year’s EPS
-0.04Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 12, 2025
|% Change Since: 19.05%
|Next Earnings Date:May 13, 2025
Earnings Call Sentiment|Positive
The earnings call presented a largely positive outlook with strong commercial growth, significant program implementation, and optimistic guidance for 2025. However, some challenges remain with slower government revenue growth and the need to ramp subscale contracts.Company Guidance
During the Performant Healthcare Fourth Quarter 2024 Earnings Conference Call, the company provided guidance indicating strong financial health and future growth prospects. Performant finished 2024 with healthcare revenue at $118.3 million, representing double-digit revenue growth, with commercial client revenue increasing by 18% and government revenue by 3%. The company anticipates 2025 revenues between $131 million and $135 million, with adjusted EBITDA expected to nearly double to a range of $8 million to $9 million. Performant highlighted its efforts to integrate AI and natural language processing technologies to enhance workflow efficiency, aiming for a 20% adjusted EBITDA margin. The company has implemented over 100 commercial programs since 2022, with an expected cumulative annual contract value of $46 million. Despite challenges, such as election-related sensitivities, Performant remains optimistic about its federal and commercial market opportunities, underpinned by a robust sales pipeline and strategic investments in technology and workforce.Strong Commercial Growth
Healthcare revenue ended the year at $118.3 million with commercial client growth of 18%. Commercial clients now account for almost 60% of healthcare revenue, up from 28% in 2021.
Record Year for Program Growth
Implemented 42 commercial programs in 2024, expected to generate over $18 million in annual revenue at steady state. Over 100 programs implemented since 2022 with an expected cumulative ACV of $46 million.
Significant Internal Achievements
Improved key talent metrics, launched an employee stock purchase plan, and received a Comparably Award for Best Company Outlook in 2024.
Positive Financial Performance
Fourth quarter healthcare revenue grew 10% year-over-year. Full-year revenue was $123 million, with healthcare revenue growing 11% to over $118 million.
Optimistic 2025 Guidance
Forecasting revenues of $131 million to $135 million for 2025 and adjusted EBITDA of $8 million to $9 million, nearly double the 2024 adjusted EBITDA at the midpoint.
---
PHLT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
PHLT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 12, 2025 | $2.52 | $2.77 | +9.92% |
| Nov 06, 2024 | $4.28 | $3.64 | -14.95% |
| Aug 07, 2024 | $3.28 | $3.65 | +11.28% |
| May 07, 2024 | $2.84 | $3.09 | +8.80% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Performant Healthcare (PHLT) report earnings?
Performant Healthcare (PHLT) is schdueled to report earning on May 13, 2025, TBA Not Confirmed.
What is Performant Healthcare (PHLT) earnings time?
Performant Healthcare (PHLT) earnings time is at May 13, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PHLT EPS forecast?
PHLT EPS forecast for the fiscal quarter 2025 (Q1) is -0.02.
---